Charles N. York II
2018
In 2018, Charles N. York II earned a total compensation of $960.8K as Chief Financial Officer and Vice President at Aeglea BioTherapeutics, a 15% decrease compared to previous year.
Compensation breakdown
| Bonus | $185,000 |
|---|---|
| Salary | $343,000 |
| Stock Awards | $424,842 |
| Other | $7,981 |
| Total | $960,823 |
York received $424.8K in stock awards, accounting for 44% of the total pay in 2018.
York also received $185K in bonus, $343K in salary and $8K in other compensation.
Rankings
In 2018, Charles N. York II's compensation ranked 9,391st out of 14,244 executives tracked by ExecPay. In other words, York earned more than 34.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,391 out of 14,244 | 34th |
Division Manufacturing | 3,763 out of 5,759 | 35th |
Major group Chemicals And Allied Products | 1,417 out of 2,122 | 33rd |
Industry group Drugs | 1,193 out of 1,811 | 34th |
Industry Pharmaceutical Preparations | 922 out of 1,385 | 33rd |
Source: SEC filing on April 22, 2019.
York's colleagues
We found two more compensation records of executives who worked with Charles N. York II at Aeglea BioTherapeutics in 2018.